Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Early Mortality in Patients with Newly Diagnosed Multiple Myeloma (NDMM): Sociodemographic and Economic Factors Contributing to the Disparity

Firas Baidoun, Ricardo D. Parrondo, Vivek Roy, Andre Fernandez, Caitlin Flott, Taimur Sher, Rami Manochakian, Asher A. Chanan-Khan, Sikander Ailawadhi

Blood (2024) 144 (Supplement 1): 4723.

https://doi.org/10.1182/blood-2024-206351

Published: 2024

Journal Articles

Disparities in Multiple Myeloma (MM): Race/Ethnicity-Specific Sociodemographic and Economic Factors That May Drive Patient Decisions to Refuse Treatment

Firas Baidoun, Vivek Roy, Ricardo D. Parrondo, Andre Fernandez, Caitlin Flott, Taimur Sher, Rami Manochakian, Asher A. Chanan-Khan, Sikander Ailawadhi

Blood (2024) 144 (Supplement 1): 3790.

https://doi.org/10.1182/blood-2024-206308

Published: 2024

Journal Articles

Understanding Patient Perspective, Challenges, Behavioral Patterns, and Preferences Towards Participation in Multiple Myeloma Clinical Trials: A Prospective Study

Sikander Ailawadhi, Jay R. Hydren, Leyla Bojanini, Nathan W. Sweeney, Felicia Seng, Mizba Baksh, Ahsan Rasheed, Mays Abdulazeez, Meghna Ailawadhi, Keren George, Ricardo D Parrondo, Vivek Roy, Victoria R. Alegria, Pooja Advani, Rami Manochakian, Jason S. Starr, Taimur Sher, Jennifer M. Ahlstrom, Asher Chanan-Khan

Blood (2022) 140 (Supplement 1): 7941–7942.

https://doi.org/10.1182/blood-2022-167005

Published: 2022

Journal Articles

Racial Disparities and Their Impact on Knowledge, Behavioral Patterns, and Preferences Towards Participation in Clinical Trials Among Cancer Patients

Meghna Ailawadhi, MD, Mays F Abdulazeez, MBBS, Leyla Bojanini Molina, MD, Victoria R. Alegria, Taimur Sher, MD, Vivek Roy, MD, Rami Manochakian, MD, Aneel Paulus, MD, Asher A. Chanan-Khan, MD, Sikander Ailawadhi

Blood (2020) 136 (Supplement 1): 39–40.

https://doi.org/10.1182/blood-2020-140390

Published: 2020

Journal Articles

Disparities and Their Impact on the Adoption of Health Information Technology (HIT) in Minority Cancer Patients and Caregivers

Sikander Ailawadhi, MD, Meghna Ailawadhi, MD, Srilekha Bodepudi, Mays F Abdulazeez, BMSC, Zan Tahir Shareef, Ashna Grover, Maria J Fernandez, Winston Tan, MD, Victoria R. Alegria, Taimur Sher, MD, Vivek Roy, MD, Rami Manochakian, MD, Aneel Paulus, MD, Asher A. Chanan-Khan, MD

Blood (2019) 134 (Supplement_1): 411.

https://doi.org/10.1182/blood-2019-125722

Published: 2019

Journal Articles

A Population-Based Analysis of Predictors of Survival and Trends in Outcomes of Elderly Patients with Multiple Myeloma (MM)

Vivek Kumar, MD, M.B.,B.S., Meghna Ailawadhi, MD, Mays F Abdulazeez, MBBS, Suman Biswas, MD, Sri Lekha Bodepudi, Leyla Bojanini, MD, Vivek Roy, MD, Taimur Sher, MD, Victoria R. Alegria, Rami Manochakian, MD, Aneel Paulus, MD, Asher A. Chanan-Khan, MD, Sikander Ailawadhi, MD

Blood (2019) 134 (Supplement_1): 4779.

https://doi.org/10.1182/blood-2019-125156

Published: 2019

Journal Articles

Opiate and Benzodiazepine Use during Hospitalization for Hematopoietic Stem Cell Transplantation (HSCT) Is Associated with Adverse Health Related Outcomes

Madiha Iqbal, MBBS, Aaron C. Spaulding, Salman Ahmed, MD, Prachi Jani, MD, Chanel Wood, Shehzad Niazi, Rami Manochakian, MD, Aneel Paulus, MD, Ernesto Ayala, MD, Mohamed A Kharfan-Dabaja, MD, Vivek Roy, MD, Asher A. Chanan-Khan, MD, Sikander Ailawadhi, Taimur Sher, MD

Blood (2018) 132 (Supplement 1): 5873.

https://doi.org/10.1182/blood-2018-99-119781

Published: 2018

Journal Articles

Impact of Depression or Anxiety on Opioid and Benzodiazepine Use in Hospitalized Hematopoietic Stem Cell Transplantation (HSCT) Recipients

Madiha Iqbal, MBBS, Aaron C. Spaulding, Chanel Wood, Salman Ahmed, MD, Prachi Jani, MD, Rami Manochakian, MD, Aneel Paulus, MD, Mohamed A Kharfan-Dabaja, MD, Ernesto Ayala, MD, Sikander Ailawadhi, Asher A. Chanan-Khan, MD, Shehzad Niazi, Taimur Sher, MD

Blood (2018) 132 (Supplement 1): 4852.

https://doi.org/10.1182/blood-2018-99-119912

Published: 2018

Journal Articles

Timeliness of Initial Therapy in Multiple Myeloma (MM): Trends and Factors Influencing Patient Care

Vivek Kumar, MD, M.B.,B.S., Taimur Sher, MD, Leyla Bojanini, MD, Prakash Vishnu, MD, Vivek Roy, MD, Rami Manochakian, MD, Sri Lekha Bodepudi, Zan Tahir Shareef, Salman Ahmed, MD, Prachi Jani, MD, Victoria R. Alegria, Meghna Ailawadhi, MD, Aneel Paulus, MD, Sonikpreet Aulakh, MD, Madiha Iqbal, MBBS, Asher A. Chanan-Khan, MD, Sikander Ailawadhi

Blood (2018) 132 (Supplement 1): 4764.

https://doi.org/10.1182/blood-2018-99-120127

Published: 2018

Journal Articles

Disparity in Clinical Trial Opportunities for Patients with B-Cell Malignancies in the United States

Sikander Ailawadhi, Sri Lekha Bodepudi, Zan Tahir Shareef, Fabiola Coromoto Cardozo, Salman Ahmed, MD, Prachi Jani, MD, Shishir David, Vivek Roy, MD, Aneel Paulus, MD, Victoria R. Alegria, Vivek Kumar, MD, M.B.,B.S., Meghna Ailawadhi, MD, Prakash Vishnu, MD, Sonikpreet Aulakh, MD, Rami Manochakian, MD, Asher A. Chanan-Khan, MD, Taimur Sher, MD

Blood (2018) 132 (Supplement 1): 4861.

https://doi.org/10.1182/blood-2018-99-117155

Published: 2018

Journal Articles

Trends in the Risk of Second Primary Malignancies (SPMs) Among Survivors of Chronic Lymphocytic Leukemia(CLL)

Vivek Kumar, MD, M.B.,B.S., Sikander Ailawadhi, Leyla Bojanini, MD, Aditya Mehta, Anshika Singh, Taimur Sher, MD, Vivek Roy, MD, Prakash Vishnu, MD, Julian A Marin-Acevedo, Victoria R. Alegria, Aneel Paulus, MD, Sonikpreet Aulakh, MD, Madiha Iqbal, MBBS, Rami Manochakian, MD, Winston Tan, MD, Asher A. Chanan-Khan, MD, Meghna Ailawadhi, MD

Blood (2018) 132 (Supplement 1): 4869.

https://doi.org/10.1182/blood-2018-99-116361

Published: 2018

Journal Articles

Computational Modelling of Multiple Myeloma Patient Genomic Signatures to Predict Treatment Outcome

Aneel Paulus, MD, Prachi Jani, MD, Salman Ahmed, MD, Sonikpreet Aulakh, MD, Alak Manna, PhD, Neeraj Kumar Singh, B.Tech, Mohammed Sauban, B.E, Zakir Husain, M.Tech, Ansu Kumar, M.Sc., Pallavi Kumari, M.Sc., Anuj Tyagi, M.Sc., Taimur Sher, MD, Rami Manochakian, MD, Vivek Roy, MD, Taher Abbasi, MS, MBA, Shireen Vali, PhD, Asher A. Chanan-Khan, MD, Sikander Ailawadhi

Blood (2018) 132 (Supplement 1): 1911.

https://doi.org/10.1182/blood-2018-99-119574

Published: 2018

Journal Articles

Final Results of a Phase II Study of Bortezomib (Velcade) in Combination with Liposomal Doxorubicin (Doxil) and Thalidomide (VDT) Demonstrate a Sustained High Response Rates in Patients (pts) with Relapsed (rel) or Refactory (ref) Multiple Myeloma.

Asher Alban Chanan-khan, MD, Swaminathan Padmanabhan, MD, Kena C. Miller, RNP, Laurie Musiel, RNP, Jihnhee Yu, Ph.D, Zale P. Bernstein, MD, Rami Manochakian, MD, Myron S. Czuczman, MD

Blood (2006) 108 (11): 3539.

https://doi.org/10.1182/blood.V108.11.3539.3539

Published: 2006

Journal Articles

Weight Adjusted Low-Dose Warfarin Decreases the Incidence of Thalidomide (T) Associated Venous Thromboembolism (VTE) in Patients (pts) with Multiple Myeloma (MM) and Waldenstroms Macroglobulinemia (WM).

Kena C. Miller, NP, Rami Manochakian, Swaminathan Padmanabhan, MD, Jean-Gabriel Coignet, Laurie Musial, Dawn DePaolo, Asher Alban Chanan-Khan, MD

Blood (2006) 108 (11): 4101.

https://doi.org/10.1182/blood.V108.11.4101.4101

Published: 2006

Journal Articles

Low-Dose Prednisone Decreases the Severity but Not the Frequency of Lenalidomide Associated Tumor Flare Feaction (TFR) in Chronic Lymphocytic Leukemia (CLL) Patients.

Laurie Musial, Kena C. Miller, Amy Tonelli, Rami Manochakian, Swaminathan Padmanabhan, David Lawrence, Dawn DePaolo, Jean-Gabriel Coignet, Asher Alban Chanan-Khan, MD

Blood (2006) 108 (11): 4987.

https://doi.org/10.1182/blood.V108.11.4987.4987

Published: 2006

Journal Articles

Incidence, Clinical Presentation and Outcome of Secondary Multiple Extramedullary Plasmacytomas: Experience at Roswell Park Cancer Institute.

Rami Manochakian, MD, Kena C. Miller, Jean-Gabriel Coignet, Swami Padmanabhan, MD, Laurie Musial, Dawn DePaolo, Asher Alban Chanan-Khan

Blood (2006) 108 (11): 5057.

https://doi.org/10.1182/blood.V108.11.5057.5057

Published: 2006

Journal Articles

Co-Expression of CD38 with Zap-70 Is Predictive of Treatment Intervention in Patients (pts) with Early Stage Chronic Lymphocytic Leukemia (CLL).

Jean-Gabriel Coignet, Swaminathan Padmanabhan, MD, Rami Manochakian, MD, Kena C. Miller, NP, Paul Wallace, Ph.D., AnneMarie Block, Ph.D., Asher Alban Chanan-Khan, MD

Blood (2006) 108 (11): 4945.

https://doi.org/10.1182/blood.V108.11.4945.4945

Published: 2006

Journal Articles

Osteonecrosis of the Jaw (ONJ) in Patients with Multiple Myeloma, Receiving Bisphosphonate Therapy, Is Independent of Renal Function: Single Institute Experience of an Emerging Clinical Problem.

Rami Manochakian, Jean-Gabriel Coignet, Swaminathan Padmanabhan, Maureen Sullivan, Kena C. Miller, Asher Alban Chanan-Khan, MD

Blood (2006) 108 (11): 5129.

https://doi.org/10.1182/blood.V108.11.5129.5129

Published: 2006

NARROW

Early Mortality in Patients with Newly Diagnosed Multiple Myeloma (NDMM): Sociodemographic and Economic Factors Contributing to the Disparity

Disparities in Multiple Myeloma (MM): Race/Ethnicity-Specific Sociodemographic and Economic Factors That May Drive Patient Decisions to Refuse Treatment

Understanding Patient Perspective, Challenges, Behavioral Patterns, and Preferences Towards Participation in Multiple Myeloma Clinical Trials: A Prospective Study

Racial Disparities and Their Impact on Knowledge, Behavioral Patterns, and Preferences Towards Participation in Clinical Trials Among Cancer Patients

Disparities and Their Impact on the Adoption of Health Information Technology (HIT) in Minority Cancer Patients and Caregivers

A Population-Based Analysis of Predictors of Survival and Trends in Outcomes of Elderly Patients with Multiple Myeloma (MM)

Opiate and Benzodiazepine Use during Hospitalization for Hematopoietic Stem Cell Transplantation (HSCT) Is Associated with Adverse Health Related Outcomes

Impact of Depression or Anxiety on Opioid and Benzodiazepine Use in Hospitalized Hematopoietic Stem Cell Transplantation (HSCT) Recipients

Timeliness of Initial Therapy in Multiple Myeloma (MM): Trends and Factors Influencing Patient Care

Disparity in Clinical Trial Opportunities for Patients with B-Cell Malignancies in the United States

Trends in the Risk of Second Primary Malignancies (SPMs) Among Survivors of Chronic Lymphocytic Leukemia(CLL)

Computational Modelling of Multiple Myeloma Patient Genomic Signatures to Predict Treatment Outcome

Final Results of a Phase II Study of Bortezomib (Velcade) in Combination with Liposomal Doxorubicin (Doxil) and Thalidomide (VDT) Demonstrate a Sustained High Response Rates in Patients (pts) with Relapsed (rel) or Refactory (ref) Multiple Myeloma.

Weight Adjusted Low-Dose Warfarin Decreases the Incidence of Thalidomide (T) Associated Venous Thromboembolism (VTE) in Patients (pts) with Multiple Myeloma (MM) and Waldenstroms Macroglobulinemia (WM).

Low-Dose Prednisone Decreases the Severity but Not the Frequency of Lenalidomide Associated Tumor Flare Feaction (TFR) in Chronic Lymphocytic Leukemia (CLL) Patients.

Incidence, Clinical Presentation and Outcome of Secondary Multiple Extramedullary Plasmacytomas: Experience at Roswell Park Cancer Institute.

Co-Expression of CD38 with Zap-70 Is Predictive of Treatment Intervention in Patients (pts) with Early Stage Chronic Lymphocytic Leukemia (CLL).

Osteonecrosis of the Jaw (ONJ) in Patients with Multiple Myeloma, Receiving Bisphosphonate Therapy, Is Independent of Renal Function: Single Institute Experience of an Emerging Clinical Problem.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only